Yadgir S, Johnson CO, Aboyans V, Adebayo OM, Adedoyin RA, Afarideh M, et al. Global, regional, and national burden of calcific aortic valve and degenerative mitral valve diseases, 1990–2017. Circulation. 2020;141(21):1670–80.

Article  PubMed  Google Scholar 

Davidson LJ, Davidson CJ. Transcatheter treatment of valvular heart disease: a review. JAMA. 2021;325(24):2480–94.

Article  PubMed  Google Scholar 

Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561–632.

Article  PubMed  Google Scholar 

Tarantini G, Mojoli M, Windecker S, Wendler O, Lefevre T, Saia F, et al. Prevalence and impact of atrial fibrillation in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis from the SOURCE XT Prospective Multicenter Registry. JACC Cardiovasc Interv. 2016;9(9):937–46.

Article  PubMed  Google Scholar 

Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–98.

Article  PubMed  Google Scholar 

Delesalle G, Bohbot Y, Rusinaru D, Delpierre Q, Marechaux S, Tribouilloy C. Characteristics and prognosis of patients with moderate aortic stenosis and preserved left ventricular ejection fraction. J Am Heart Assoc. 2019;8(6): e011036.

Article  PubMed  PubMed Central  Google Scholar 

Hoffman M, Monroe DM. Impact of non-vitamin K antagonist oral anticoagulants from a basic science perspective. Arterioscler Thromb Vasc Biol. 2017;37(10):1812–8.

Article  PubMed  PubMed Central  Google Scholar 

Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383(9921):955–62.

Article  PubMed  Google Scholar 

Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498.

Article  PubMed  Google Scholar 

Sannino A, Gargiulo G, Schiattarella GG, Perrino C, Stabile E, Losi MA, et al. A meta-analysis of the impact of pre-existing and new-onset atrial fibrillation on clinical outcomes in patients undergoing transcatheter aortic valve implantation. EuroIntervention. 2016;12(8):e1047–56.

Article  PubMed  Google Scholar 

Patti G, Pecen L, Lucerna M, Huber K, Rohla M, Renda G, et al. Net clinical benefit of non-vitamin K antagonist vs vitamin K antagonist anticoagulants in elderly patients with atrial fibrillation. Am J Med. 2019;132(6):749-57e5.

Article  PubMed  Google Scholar 

Bromley A, Plitt A. A review of the role of non-vitamin K oral anticoagulants in the acute and long-term treatment of venous thromboembolism. Cardiol Ther. 2018;7(1):1–13.

Article  PubMed  PubMed Central  Google Scholar 

Coulis AA, Mackey WC. A review of the efficacy and safety profiles of the novel oral anticoagulants in the treatment and prevention of venous thromboembolism. Clin Ther. 2018;40(12):2140–67.

Article  PubMed  Google Scholar 

Collet JP, Van Belle E, Thiele H, Berti S, Lhermusier T, Manigold T, et al. Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial. Eur Heart J. 2022;43(29):2783–97.

Article  PubMed  Google Scholar 

Dangas GD, Tijssen JGP, Wohrle J, Sondergaard L, Gilard M, Mollmann H, et al. A controlled trial of rivaroxaban after transcatheter aortic-valve replacement. N Engl J Med. 2020;382(2):120–9.

Article  PubMed  Google Scholar 

Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e35–71.

PubMed  Google Scholar 

Alaour B, Ferrari E, Heg D, Tueller D, Pilgrim T, Muller O, et al. Non-vitamin K antagonist versus vitamin K antagonist oral anticoagulant agents after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2024;17(3):405–18.

Article  PubMed  Google Scholar 

Steffel J, Collins R, Antz M, Cornu P, Desteghe L, Haeusler KG, et al. 2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Europace. 2021;23(10):1612–76.

Article  PubMed  Google Scholar 

Yao X, Shah ND, Sangaralingham LR, Gersh BJ, Noseworthy PA. Non-Vitamin K antagonist oral anticoagulant dosing in patients with atrial fibrillation and renal dysfunction. J Am Coll Cardiol. 2017;69(23):2779–90.

Article  PubMed  Google Scholar 

Chen A, Stecker E, Warden BA. direct oral anticoagulant use: a practical guide to common clinical challenges. J Am Heart Assoc. 2020;9(13): e017559.

Article  PubMed  PubMed Central  Google Scholar 

Kappetein AP, Head SJ, Genereux P, Piazza N, van Mieghem NM, Blackstone EH, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol. 2012;60(15):1438–54.

Article  PubMed  Google Scholar 

Sanghai S, Wong C, Wang Z, Clive P, Tran W, Waring M, et al. Rates of potentially inappropriate dosing of direct-acting oral anticoagulants and associations with geriatric conditions among older patients with atrial fibrillation: the SAGE-AF Study. J Am Heart Assoc. 2020;9(6): e014108.

Article  PubMed  PubMed Central  Google Scholar 

Diez-Villanueva P, Cosin-Sales J, Roldan-Schilling V, Barrios V, Riba-Artes D, Gavin-Sebastian O, et al. Use of direct acting oral anticoagulants in elderly patients with atrial fibrillation: a multicenter, cross-sectional study in Spain. J Clin Med. 2023;12(3):1224.

Article  PubMed  PubMed Central  Google Scholar 

Geis NA, Kiriakou C, Chorianopoulos E, Uhlmann L, Katus HA, Bekeredjian R. NOAC monotherapy in patients with concomitant indications for oral anticoagulation undergoing transcatheter aortic valve implantation. Clin Res Cardiol. 2018;107(9):799–806.

Article  PubMed  Google Scholar 

Caso V, de Groot JR, Sanmartin Fernandez M, Segura T, Blomstrom-Lundqvist C, Hargroves D, et al. Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis. Heart. 2023;109(3):178–85.

Article  PubMed  Google Scholar 

Van Mieghem NM, Nuis RJ, Tzikas A, Piazza N, Schultz C, Serruys PW, et al. Prevalence and prognostic implications of baseline anaemia in patients undergoing transcatheter aortic valve implantation. EuroIntervention. 2011;7(2):184–91.

Article  PubMed  Google Scholar 

Twomley KM, Rao SV, Becker RC. Proinflammatory, immunomodulating, and prothrombotic properties of anemia and red blood cell transfusions. J Thromb Thrombolysis. 2006;21(2):167–74.

Article  PubMed  Google Scholar 

Bagur R, Webb JG, Nietlispach F, Dumont E, De Larochelliere R, Doyle D, et al. Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J. 2010;31(7):865–74.

Article  PubMed  Google Scholar 

Moore FA, Moore EE, Sauaia A. Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surg. 1997;132(6):620–4.

Article  PubMed  Google Scholar 

Sugrue A, Sanborn D, Amin M, Farwati M, Sridhar H, Ahmed A, et al. Inappropriate dosing of direct oral anticoagulants in patients with atrial fibrillation. Am J Cardiol. 2021;144:52–9.

Article  PubMed  Google Scholar 

Amoey DC, Thranitz J, Munte TF, Royl G. Acute stroke and atrial fibrillation: risk of incorrect NOAC dosage when estimating renal function from plasma creatinine only. Front Neurol. 2022;13: 907912.

Article  PubMed  PubMed Central  Google Scholar 

Carrero JJ, Hecking M, Chesnaye NC, Jager KJ. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol. 2018;14(3):151–64.

Article  PubMed  Google Scholar 

Wetmore JB, Roetker NS, Yan H, Reyes JL, Herzog CA. Direct-acting oral anticoagulants versus warfarin in Medicare patients with chronic kidney disease and atrial fibrillation. Stroke. 2020;51(8):2364–73.

Article